MedTrace Logo

Different Administration Routes of Dexmedetomidine on Postoperative Delirium

NCT05952050 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-07-19

No results posted yet for this study

Summary

Intravenous dexmedetomidine has been reported to decrease the occurrence of postoperative delirium (POD) in elderly patients. Nevertheless, some previous studies have indicated that intratracheal dexmedetomidine and intranasal dexmedetomidine are also effective and convenient. The current study aimed to compare the effect of different administration routes of dexmedetomidine on POD in elderly patients.

Conditions

  • Dexmedetomidine
  • Postoperative Delirium
  • General Anesthesia

Interventions

DRUG

Dexmedetomidine

Different Administration Routes of Dexmedetomidine

Sponsors & Collaborators

  • Zhongshan Hospital Of Traditional Chinese Medicine

    collaborator OTHER

  • Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2023-08-01
Completion
2023-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05952050 on ClinicalTrials.gov